O04 Serum nuclear magnetic resonance metabolomic signature can discriminate immunoglobulin G4-related sclerosing cholangitis and primary sclerosing cholangitis
Emmanuel Selvaraj(John Radcliffe Hospital), Fay Probert(University of Oxford), Emma Culver(John Radcliffe Hospital), Daniel C. Anthony(University of Oxford), Adam Bailey(University of Oxford), Michael Pavlides(National Institute for Health and Care Research), Alessandra Geremia(John Radcliffe Hospital), Daniel Radford‐Smith(Warneford Hospital), Rory Peters(University of Oxford), Kate D. Lynch(Royal Adelaide Hospital)
Cited by 0
Related Papers
IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
|The Journal of Experimental Medicine|2011|623
Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
|Journal of Hepatology|2013|481
IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies
|Nature Medicine|2021|289
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases
|Hepatology International|2020|130
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123